Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • Leadership
    • Team
    • Publications
    • Careers
  • Diseases/Disorders
    • One Brain
    • ALS
    • Alzheimer’s
    • Autism
    • Brain Cancer
    • Brain Injury
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • Other
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
  • Ways To Give
    • Giving to Research
    • How You Can Help
    • Events

Funded Grants

Back to results

Decoding the RNA stability programs that determine cell identity and function in human brain and neurodegenerative disorders

Project Overview

The brain cells in Alzheimer’s disease patients differ extensively from healthy brain cells at the molecular level: there are hundreds of genes that are normally active in the brain, but become inactive in Alzheimer’s. Similarly, Alzheimer’s disease appears to turn on hundreds of genes that are normally inactive in the brain. We have recently found that degradation of RNA molecules, which are the gene products that carry the genetic information in the cell, plays an important role in mediating these changes in Alzheimer’s. However, the identity and nature of the cellular factors that lead to irregular degradation of RNAs remain mostly unknown. In this project, we will study genomic data from hundreds of individuals and laboratory models of Alzheimer’s to understand what factors drive the irregular RNA degradation in the brain cells, and how they contribute to the cellular changes that we observe in the brain of Alzheimer’s disease patients. We will also examine the role of these molecular factors in different cell types of the brain, in order to understand their functions in the brain and the cell types that are affected by their malfunction in Alzheimer’s. These studies provide new insights into the fundamental biology of brain, factors that contribute to Alzheimer’s, and potential strategies for development of new therapeutic approaches.

Principal Investigator

Hamed Najafabadi , McGill University

Partners and Donors

Azrieli Foundation

Project Ongoing

Decoding the RNA stability programs that determine cell identity and function in human brain and neurodegenerative disorders

  • Program Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Azrieli Foundation – Brain Canada Early-Career Capacity Building grants

  • Province

    Québec

  • Start Date

    2019

  • Total Grant Amount

    $100,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2023 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co